Literature DB >> 33315508

Prevalence of nocturia after brain injury: a cross-sectional study in a single rehabilitation center.

Stefania Musco1, Donatella Giraudo2, Elena Antoniono3, Giuseppe Lombardi1, Giulio Del Popolo1, Vincenzo Li Marzi4, Gianfranco Lamberti5.   

Abstract

Aim: to analyze the prevalence of nocturia and its possible neuro-urological correlations in patients with a history of acquired brain injury (ABI).
Methods: a single-centre population-based prospective study involving outpatients who were previously admitted to our Rehabilitation Hospital for acute ABI ≥ 18 months and ≤2 years prior. Impact of nocturia on QoL was evaluated by the standardized International Consultation on Incotinence Nocturia Quality of Life (ICIQ N-QoL). All participants were given a three-day frequency chart. Probability value <0.05 was statistically significant.
Results: 48/138 subjects (35%) showed nocturia at 2-year follow-up visit. No, significant differences in age, gender, duration of coma, state of consciousness, disability, cognitive impairment and stroke severity were found in patients with or without nocturia. Subarachnoid haemorrhage (ESA) was the main reason for ABI in subjects showing nocturia (p = .037). The overall ICIQ N-QOL score ranged from 12 to 50 (mean 30.12 ± 8.87). Of them, 75% showed a total score >26. Increased diurnal frequency and small bladder capacity was statistically significantly associated with nocturia (p < .05).Conclusions: the rate of nocturia 2 years following ABI was lower compared to other neurological populations, although it was significantly associated with other storage urinary symptoms.

Entities:  

Keywords:  Brain injury; neurogenic bladder; nocturia; suprapontine lesion

Mesh:

Year:  2020        PMID: 33315508     DOI: 10.1080/02699052.2020.1858496

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  1 in total

1.  Development of Early-Stage Stroke Diagnosis System for the Elderly Neurogenic Bladder Prevention.

Authors:  Eui-Sun Kim; Ji-Min Heo; Sung-Jong Eun; Jun Young Lee
Journal:  Int Neurourol J       Date:  2022-02-28       Impact factor: 2.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.